{"id":{"repo_id":"ethz","oai_identifier":"oai:www.research-collection.ethz.ch:20.500.11850/156048"},"canonical_url":"https://search.dev.ndltd.org/etd/ethz/oai:www.research-collection.ethz.ch:20.500.11850/156048","repository":{"repo_id":"ethz","name":"ETH Zürich","base_url":"https://www.research-collection.ethz.ch/oai/request"},"display":{"title":"Engineered cytokine derivatives for targeted cancer immunotherapy","abstract":"","abstract_html":null,"abstract_has_math":false,"creators":["Venetz, Dario"],"institution":"ETH Zurich","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Neri, Dario; id_orcid0000-0001-5234-7370","Halin, Cornelia"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016","date_published":"2016","updated_at":"2026-07-27T19:28:35Z","subjects":["KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ZYTOKINE (IMMUNOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); INTERLEUKIN-12 (IMMUNOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS; TARGETED DRUGS (PHARMACOLOGY); CYTOKINES (IMMUNOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); INTERLEUKIN-12 (IMMUNOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"],"languages":["en"],"rights":["info:eu-repo/semantics/openAccess","In Copyright - Non-Commercial Use Permitted"],"rights_urls":["http://rightsstatements.org/page/InC-NC/1.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://doi.org/10.3929/ethz-a-010792885"],"render_values":[{"text":"https://doi.org/10.3929/ethz-a-010792885","href":"https://doi.org/10.3929/ethz-a-010792885","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/20.500.11850/156048","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Neri, Dario; id_orcid0000-0001-5234-7370","Halin, Cornelia"]},{"key":"dc:creator","label":"Author","values":["Venetz, Dario"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016"]},{"key":"dc:publisher","label":"Institution","values":["ETH Zurich"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ZYTOKINE (IMMUNOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); INTERLEUKIN-12 (IMMUNOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS; TARGETED DRUGS (PHARMACOLOGY); CYTOKINES (IMMUNOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); INTERLEUKIN-12 (IMMUNOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess","http://rightsstatements.org/page/InC-NC/1.0/","In Copyright - Non-Commercial Use Permitted"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/20.500.11850/156048","https://doi.org/10.3929/ethz-a-010792885"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:format","label":"Dc Format","values":["application/application/pdf"]},{"key":"dc:title","label":"Title","values":["Engineered cytokine derivatives for targeted cancer immunotherapy"]}]}],"canonical_facts":{"dc:contributor":["Neri, Dario; id_orcid0000-0001-5234-7370","Halin, Cornelia"],"dc:creator":["Venetz, Dario"],"dc:date":["2016"],"dc:format":["application/application/pdf"],"dc:identifier":["http://hdl.handle.net/20.500.11850/156048","https://doi.org/10.3929/ethz-a-010792885"],"dc:language":["en"],"dc:publisher":["ETH Zurich"],"dc:rights":["info:eu-repo/semantics/openAccess","http://rightsstatements.org/page/InC-NC/1.0/","In Copyright - Non-Commercial Use Permitted"],"dc:subject":["KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ZYTOKINE (IMMUNOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); INTERLEUKIN-12 (IMMUNOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS; TARGETED DRUGS (PHARMACOLOGY); CYTOKINES (IMMUNOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); INTERLEUKIN-12 (IMMUNOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"],"dc:title":["Engineered cytokine derivatives for targeted cancer immunotherapy"],"dc:type":["info:eu-repo/semantics/doctoralThesis"]},"updated_at":"2026-07-27T19:28:35Z"}